These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
318 related articles for article (PubMed ID: 26873788)
1. Harnessing the integrated stress response for the treatment of multiple sclerosis. Way SW; Popko B Lancet Neurol; 2016 Apr; 15(4):434-43. PubMed ID: 26873788 [TBL] [Abstract][Full Text] [Related]
2. Sephin1, which prolongs the integrated stress response, is a promising therapeutic for multiple sclerosis. Chen Y; Podojil JR; Kunjamma RB; Jones J; Weiner M; Lin W; Miller SD; Popko B Brain; 2019 Feb; 142(2):344-361. PubMed ID: 30657878 [TBL] [Abstract][Full Text] [Related]
3. Pharmaceutical integrated stress response enhancement protects oligodendrocytes and provides a potential multiple sclerosis therapeutic. Way SW; Podojil JR; Clayton BL; Zaremba A; Collins TL; Kunjamma RB; Robinson AP; Brugarolas P; Miller RH; Miller SD; Popko B Nat Commun; 2015 Mar; 6():6532. PubMed ID: 25766071 [TBL] [Abstract][Full Text] [Related]
12. Remyelination in multiple sclerosis: cellular mechanisms and novel therapeutic approaches. Olsen JA; Akirav EM J Neurosci Res; 2015 May; 93(5):687-96. PubMed ID: 25287108 [TBL] [Abstract][Full Text] [Related]
13. Sphingosine-1-phosphate and oligodendrocytes: from cell development to the treatment of multiple sclerosis. Coelho RP; Saini HS; Sato-Bigbee C Prostaglandins Other Lipid Mediat; 2010 Apr; 91(3-4):139-44. PubMed ID: 19808013 [TBL] [Abstract][Full Text] [Related]
14. Enhanced integrated stress response promotes myelinating oligodendrocyte survival in response to interferon-gamma. Lin W; Kunkler PE; Harding HP; Ron D; Kraig RP; Popko B Am J Pathol; 2008 Nov; 173(5):1508-17. PubMed ID: 18818381 [TBL] [Abstract][Full Text] [Related]
15. Promotion of Remyelination by Sulfasalazine in a Transgenic Zebrafish Model of Demyelination. Kim S; Lee YI; Chang KY; Lee DW; Cho SC; Ha YW; Na JE; Rhyu IJ; Park SC; Park HC Mol Cells; 2015 Nov; 38(11):1013-21. PubMed ID: 26549504 [TBL] [Abstract][Full Text] [Related]
16. Manipulation of Oxygen and Endoplasmic Reticulum Stress Factors as Possible Interventions for Treatment of Multiple Sclerosis: Evidence for and Against. Eggleton P; Smerdon GR; Holley JE; Gutowski NJ Adv Exp Med Biol; 2017; 958():11-27. PubMed ID: 28093705 [TBL] [Abstract][Full Text] [Related]
17. Non-steroidal anti-inflammatory drug indometacin enhances endogenous remyelination. Preisner A; Albrecht S; Cui QL; Hucke S; Ghelman J; Hartmann C; Taketo MM; Antel J; Klotz L; Kuhlmann T Acta Neuropathol; 2015 Aug; 130(2):247-61. PubMed ID: 25943886 [TBL] [Abstract][Full Text] [Related]
18. Quantifying immunohistochemical staining of phospho-eIF2alpha, heme oxygenase-2 and NADPH cytochrome P450 reductase in oligodendrocytes during experimental autoimmune encephalomyelitis. Chakrabarty A; Fleming KK; Marquis JG; LeVine SM J Neurosci Methods; 2005 Jun; 144(2):227-34. PubMed ID: 15910982 [TBL] [Abstract][Full Text] [Related]
19. Multiple sclerosis: neuroprotective alliance of estrogen-progesterone and gender. Kipp M; Amor S; Krauth R; Beyer C Front Neuroendocrinol; 2012 Jan; 33(1):1-16. PubMed ID: 22289667 [TBL] [Abstract][Full Text] [Related]
20. Immunomodulation neuroprotection and remyelination - the fundamental therapeutic effects of glatiramer acetate: a critical review. Aharoni R J Autoimmun; 2014 Nov; 54():81-92. PubMed ID: 24934599 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]